Evidence map›Paper›PMID 37221971›Full record

ArticleJournal of the International AIDS Society2023

Spatio-temporal changes in pre-exposure prophylaxis uptake among MSM in mainland France between 2016 and 2021: a Bayesian small area approach with MSM population estimation.

Haoyi Wang, Jean-Michel Molina, Rosemary Dray-Spira, Axel J Schmidt, Ford Hickson, David van de Vijver, Kai J Jonas

Open access · goldAbstract read
In one paragraph

Article in Journal of the International AIDS Society, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 20 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Likelihood of HIV and recent bacterial sexually transmitted infections among transgender and non-binary individuals in 20 European countries, October 2023 to April 2024.Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2024
    Article
  8. Article
  9. On the risk of using raw regional data on new HIV infections in France.Journal of the International AIDS Society · 2024
    Article
  10. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 4 countries.

Haoyi WangDepartment of Work and Social Psychology, Maastricht University, Maastricht, the Netherlands.ORCID 0000-0002-1844-7156
Jean-Michel MolinaDepartment of Infectious Diseases, Hôpital Saint-Louis, University of Paris Cité, Paris, France.ORCID 0000-0001-8684-2214
Rosemary Dray-SpiraEPI-PHARE, French National Agency for Medicines and Health Products Safety (ANSM) and French National Health Insurance (CNAM), Saint-Denis, France.ORCID 0000-0001-7646-3667
Axel J SchmidtSigma Research, London School of Hygiene and Tropical Medicine, London, UK.ORCID 0000-0002-6910-4399
Ford HicksonSigma Research, London School of Hygiene and Tropical Medicine, London, UK.ORCID 0000-0003-0395-374X
David van de VijverViroscience Department, Erasmus Medical Centre, Rotterdam, the Netherlands.ORCID 0000-0001-5877-8526
Kai J JonasDepartment of Work and Social Psychology, Maastricht University, Maastricht, the Netherlands.ORCID 0000-0001-6607-1993
London School of Hygiene & Tropical Medicine · GBMaastricht University · NLConservatoire National des Arts et Métiers · FRErasmus University Rotterdam · NLUniversité Paris Cité · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionIn France, oral pre-exposure prophylaxis (PrEP) for HIV prevention has been publicly available since 2016, mainly targeting at men who have sex with men (MSM). Reliable and robust estimations of the actual PrEP uptake among MSM on a localized level can provide additional insights to identify and better reach marginalized MSM within current HIV prevention service provision. This study used national pharmaco-epidemiology surveillance data and regional MSM population estimations to model the spatio-temporal distribution of PrEP uptake among MSM in France 2016-2021 to identify marginalized MSM at risk for HIV and increase their PrEP uptake.

methodsWe first applied Bayesian spatial analyses with survey-surveillance-based HIV incidence data as a spatial proxy to estimate the size of (1) regional HIV-negative MSM populations and (2) MSM who could be eligible for PrEP use according to French PrEP guidelines. We then applied Bayesian spatio-temporal ecological regression modelling to estimate the regional prevalence and relative probability of the overall- and new-PrEP uptake from 2016 to 2021 across France.

resultsHIV-negative and PrEP-eligible MSM populations vary regionally across France. Île-de-France was estimated to have the highest MSM density compared to other French regions. According to the final spatio-temporal model, the relative probability of overall PrEP uptake was heterogeneous across France but remained stable over time. Urban areas have higher-than-average probabilities of PrEP uptake. The prevalence of PrEP use increased steadily (ranging from 8.8% [95% credible interval 8.5%;9.0%] in Nouvelle-Aquitaine to 38.2% [36.5%;39.9%] in Centre-Val-de-Loire in 2021).

conclusionsOur results show that using Bayesian spatial analysis as a novel methodology to estimate the localized HIV-negative MSM population is feasible and applicable. Spatio-temporal models showed that despite the increasing prevalence of PrEP use in all regions, geographical disparities and inequalities of PrEP uptake continued to exist over time. We identified regions that would benefit from greater tailoring and delivery efforts. Based on our findings, public health policies and HIV prevention strategies could be adjusted to better combat HIV infections and to accelerate ending the HIV epidemic.

Indexed as

HIV InfectionsPre-Exposure ProphylaxisSexual and Gender MinoritiesBayes TheoremFranceHomosexuality, MaleHumansMaleBayesian spatio-temporal analysisHIV preventionmen who have sex with men (MSM)MSM population estimationpre-exposure prophylaxis (PrEP)small area estimation

Identifiers

PMID37221971
PMCPMC10206410
OpenAlexW4377940397

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.